These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6595214)

  • 1. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
    Shetty PA; Kurkure PA; Dasgupta A
    Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
    Freeman AI
    Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
    Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
    Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate followed by L-asparaginase for the treatment of acute non lymphoid leukemia.
    Tribalto M; Amadori S; Avvisati G; Del Bianco P; Franchi A; Gallerano T; Papa G; Mandelli F
    Haematologica; 1985; 70(4):319-23. PubMed ID: 3935530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
    Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
    Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intensification of treatment of lymphoblastic leukemia in children].
    Michalewska D; Radwańska U
    Pediatr Pol; 1985 Jan; 60(1):5-13. PubMed ID: 3862059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study on the treatment of acute lymphoblastic leukemia with T-cell markers in children].
    Nishikawa A; Saito K; Taniuchi S; Ohnishi T; Matsumura T
    Rinsho Ketsueki; 1984 May; 25(5):660-5. PubMed ID: 6332214
    [No Abstract]   [Full Text] [Related]  

  • 8. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.
    Capizzi RL
    Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a polychemotherapeutic regimen including Idarubicin (4-demethoxydaunorubicin) in relapsed acute lymphocytic leukemia.
    Mandelli F; Testi AM; Aloe Spiriti MA; Giona F; Meloni G; Moleti ML; Amadori S; Pacciarini MA
    Haematologica; 1986; 71(1):34-8. PubMed ID: 3084353
    [No Abstract]   [Full Text] [Related]  

  • 10. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults.
    Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65 Suppl 1():83-7. PubMed ID: 6948610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Remission induction with vincristine and prednisolone alone in adult acute lymphocytic leukemia].
    Saito K; Kajitani H; Okuyama A; Osato M; Hara M; Watanabe K; Dobashi Y; Yamazaki T; Hamaguchi H; Sakamaki H
    Rinsho Ketsueki; 1984 Sep; 25(9):1388-93. PubMed ID: 6596449
    [No Abstract]   [Full Text] [Related]  

  • 12. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD).
    Hui L; Wiernik PH
    Am J Hematol; 1996 Jul; 52(3):184-8. PubMed ID: 8756084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the results of treatment of lymphoblastic leukemia in children by different methods].
    Derulska D; Rokicka-Milewska R; Skrobowska-Woźniak A; Makowska K; Kansy J
    Pediatr Pol; 1981 Sep; 56(9):985-92. PubMed ID: 6948273
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia.
    Willemze R; Fibbe WE; Zwaan FE
    Neth J Med; 1983; 26(8):215-9. PubMed ID: 6580554
    [No Abstract]   [Full Text] [Related]  

  • 15. [L-Asparaginase in the treatment of acute leukemia].
    Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
    Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ; Blatt J; Sather HN; Meadows AT
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
    Kamen BA; Casper J; Lauer S; Camitta BM; Holcenberg JS
    Cancer Treat Rep; 1986 Jul; 70(7):935-6. PubMed ID: 3459577
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
    Capizzi RL; Powell BL; Cooper MR; Stuart JJ; Muss HB; Richards F; Jackson DV; White DR; Spurr CL; Zekan PJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):105-13. PubMed ID: 3892697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with polyethylene glycol-bound E. coli L-asparaginase in patients with multiple recurrences of acute lymphoblastic leukemia].
    Jürgens H; Schwamborn D; Körholz D; Wahn V; Göbel U
    Klin Padiatr; 1988; 200(3):184-9. PubMed ID: 3210651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transient cerebral dysfunction induced by VCR, HD-MTX in a child with acute lymphocytic leukemia].
    Sato J; Yuasa Y; Tanaka H; Ninomiya T; Hirose M; Miyao M
    Rinsho Ketsueki; 1986 Nov; 27(11):2162-7. PubMed ID: 3469437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.